Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.
Immuno-oncology: Pushing the frontier of discovery through advanced high throughput flow cytometry
Immunotherapy: Pushing the Frontier of Cancer Medicine
Can the Cancer 'Moonshot' and Immunotherapy Cure Cancer? - The Atlantic
Louis Boon on LinkedIn: 2018 medicine laureates on their cancer therapy
Snapshot of a Year in Progress
The future of cancer immunotherapy: microenvironment-targeting combinations
American Association for Cancer Research (AACR)
Transforming Lives through Innovative Cancer Science
Reducing Cancer Risk AACR Cancer Progress Report 2023
Immunotherapy: Pushing the Frontier of Cancer Medicine
/medriva/media/media_files/2326df921e3cab9959ccbaa584d9f371d518851415f8a0327be4fa0fb0e46d96.jpg)
A Bold Shift in Cancer Treatment: Lower Doses, Reduced Costs, and Enhanced Quality of Life
Personalized Cancer Immunotherapy
